ARCHIVES

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

This article is from The Cancer Letter archive.

Vol. 07 No. 33 | August 14, 1981

Download PDF Visit The Full Archive

Related Articles

Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life

October 27, 2006

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

Rumors Preceded Broder’s Move

December 22, 1994

Professional Societies: AACR Presents Awards At Annual Meeting

April 18, 1997

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002